FDA Brief

Company record

HTO Nevada, Inc. dba Kirkman

1 FDA warning letter since 2023 and 3 recalls in the last 12 months.

Get an email the day FDA posts anything new about HTO Nevada, Inc. dba Kirkman.

Warning letters

  1. HTO Nevada, Inc. dba Kirkman

    HTO Nevada dba Kirkman, an OTC drug contract manufacturer, was cited for CGMP violations including mislabeled reformulated drugs.

    High risk

Recalls

ReportedClassFirmProduct and reason
Mar 11 Class II HTO Nevada Inc. dba Kirkman
Drug
FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-016.
Stability Data Does Not Support Expiry Date.
Mar 11 Class II HTO Nevada Inc. dba Kirkman
Drug
MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015.
Stability Data Does Not Support Expiry Date.
Mar 11 Class II HTO Nevada Inc. dba Kirkman
Drug
MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-014.
Stability Data Does Not Support Expiry Date.